Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.
- FY26 revenue rose 31% to $19.87 million
- Net loss of $417,754 after a FY25 profit
- $1.69 million operating cash flow and $2.93 million cash balance
- QBMC development approvals secured after year end
- $2 million mine dewatering contract awarded for FY27
Revenue Growth Comes With a Funding Warning
Parkway Corporate Limited (ASX:PWN) grew FY26 sales by 31% to $19.87 million, yet the water and wastewater technology company ended the year with a $417,754 net loss after recording a $15,915 profit in FY25. The more consequential disclosure sits deeper in the accounts: Parkway says there is a significant uncertainty over going concern if it cannot win forecast contracts, improve margins, receive its expected research and development rebate and generate enough cash to repay a $2 million term loan due in June 2027.
The result was not a cash-flow failure. Parkway generated $1.69 million in net operating cash during the year, up from $1.46 million, and finished with $2.93 million in cash. But the balance sheet also carried $2.02 million in current borrowings, while trade and other payables rose to $3.64 million from $2.00 million. The directors say they expect to have sufficient cash for at least 12 months from signing, while explicitly acknowledging that not all forecast revenue is backed by contracts at the reporting date.
Municipal Project Powered the Industrial Division
Parkway Process Solutions delivered record operating revenue as work accelerated on a major municipal resource recovery project. Water industry fabrication and installation services generated $16.51 million, compared with $11.58 million a year earlier, and accounted for most of the group’s total sales. Revenue from John Holland Group alone was approximately $11.13 million, more than half of FY26 revenue, highlighting both the scale of the contract and the customer concentration attached to it.
The project remained active after year end, but Parkway expects revenue growth to moderate from the second quarter of FY27 as it approaches completion. The company is therefore relying on its wider opportunity pipeline, new industrial customers and an expanded accredited vendor base to replace some of that volume. A $2 million mine dewatering contract awarded on 31 August is due to contribute to FY27 revenue and earnings, providing an early test of whether the broader pipeline can carry more weight.
QBMC Clears Primary Approval Hurdles
Parkway’s longer-term proposition advanced materially after year end when Queensland Brine Solutions secured Western Downs Regional Council approval for Stages 0 and 1 of the Queensland Brine Management Complex. The approval incorporates the Environmental Authority and State-Controlled Road Access Permit secured during FY26, allowing the proposed commercial demonstration project and first full-scale commercial stage to move further through development.
QBMC is intended to process regulated waste brines from sources including coal seam gas, mining and industrial water treatment, converting contained salts into industrial chemicals. Parkway has also signed a binding memorandum of understanding with Hitachi to develop modular ultra-high brine concentration systems that could be deployed at QBMC and supplied to third-party customers. However, the approval is not a final investment decision: remaining permits, commercial arrangements, funding and engineering work still stand between approval and construction.
Execution Must Catch Up With the Project Case
Parkway’s preliminary Stage 1 development metrics include an internal rate of return above 30% and a post-tax net present value above $700 million at a 10% discount rate. Those figures remain subject to feasibility refinement, negotiations, funding and final investment decisions. Meanwhile, the group capitalised a further $1.59 million of research and development expenditure in FY26, lifting intangible assets to $9.51 million, with no impairment recognised after management’s testing.
That accounting outcome does not remove the commercial question. Parkway’s future depends on converting project opportunities into contracted work, protecting margins as the flagship municipal project winds down and finding an acceptable funding path for QBMC. The annual report also records 216.22 million options and performance rights outstanding against 2.77 billion issued shares, a potential source of future dilution if those instruments ultimately convert. The next markers are concrete: FY27 delivery of the mine dewatering contract, replacement work for the municipal project and evidence that QBMC can secure the remaining capital and commercial commitments.
Bottom Line?
Parkway has moved its projects forward, but the investment case now turns on contract conversion, margin delivery and funding the path from QBMC approval to construction.
Questions in the middle?
- Can Parkway replace the municipal project’s revenue contribution before growth moderates from Q2 FY27?
- Will operating cash flow and the expected R&D rebate be sufficient to meet the $2 million term loan repayment due in June 2027?
- What funding and commercial arrangements will be secured before QBMC proceeds beyond its demonstration and approval stages?